ZCY logo

Cryo-Cell International DB:ZCY Stock Report

Last Price

€3.98

Market Cap

€34.7m

7D

-10.8%

1Y

-44.7%

Updated

06 May, 2025

Data

Company Financials +

Cryo-Cell International, Inc.

DB:ZCY Stock Report

Market Cap: €34.7m

ZCY Stock Overview

Engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. More details

ZCY fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health1/6
Dividends2/6

Rewards

Became profitable this year

Risk Analysis

Interest payments are not well covered by earnings

Highly volatile share price over the past 3 months compared to the German market

Earnings are forecast to decline by an average of 70.5% per year for the next 3 years

Dividend of 20.79% is not well covered by earnings or free cash flows

+ 3 more risks

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Cryo-Cell International, Inc. Competitors

FamiCord

XTRA:V3V

€68.0m

Maternus-Kliniken

XTRA:MAK

€32.5m

Gesundheitswelt Chiemgau

MUN:JTH

€24.2m

SYNLAB

HMSE:SYAB

€2.8b

Price History & Performance

Summary of share price highs, lows and changes for Cryo-Cell International
Historical stock prices
Current Share PriceUS$3.98
52 Week HighUS$9.35
52 Week LowUS$2.92
Beta0.81
1 Month Change-24.91%
3 Month Changen/a
1 Year Change-44.72%
3 Year Changen/a
5 Year Changen/a
Change since IPO-9.55%

Recent News & Updates

Recent updates

Shareholder Returns

ZCYDE HealthcareDE Market
7D-10.8%5.6%2.5%
1Y-44.7%39.7%13.4%

Return vs Industry: ZCY underperformed the German Healthcare industry which returned 35.1% over the past year.

Return vs Market: ZCY underperformed the German Market which returned 15% over the past year.

Price Volatility

Is ZCY's price volatile compared to industry and market?
ZCY volatility
ZCY Average Weekly Movement18.6%
Healthcare Industry Average Movement6.2%
Market Average Movement6.4%
10% most volatile stocks in DE Market12.9%
10% least volatile stocks in DE Market3.1%

Stable Share Price: ZCY's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: ZCY's weekly volatility has decreased from 36% to 19% over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
198984David Portnoywww.cryo-cell.com

Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells.

Cryo-Cell International, Inc. Fundamentals Summary

How do Cryo-Cell International's earnings and revenue compare to its market cap?
ZCY fundamental statistics
Market cap€34.67m
Earnings (TTM)€113.15k
Revenue (TTM)€28.22m

302.0x

P/E Ratio

1.2x

P/S Ratio

Is ZCY overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ZCY income statement (TTM)
RevenueUS$32.10m
Cost of RevenueUS$7.87m
Gross ProfitUS$24.24m
Other ExpensesUS$24.11m
EarningsUS$128.71k

Last Reported Earnings

Feb 28, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.016
Gross Margin75.50%
Net Profit Margin0.40%
Debt/Equity Ratio-88.8%

How did ZCY perform over the long term?

See historical performance and comparison

Dividends

20.8%

Current Dividend Yield

3,140%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/06 05:39
End of Day Share Price 2025/05/06 00:00
Earnings2025/02/28
Annual Earnings2024/11/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cryo-Cell International, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Allen KleeMaxim Group